What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives 
From Lab to Global Impact: Polyrizon’s Journey to Potentially Redefining Next-Generation Nasal Protection
Ra’anana, Israel , Dec. 04, 2025 (GLOBE NEWSWIRE) -- In an era where airborne threats like allergens and viruses disrupt...
Plus Therapeutics Highlights Three REYOBIQ™ Clinical Data Presentations at 2025 WFNOS/SNO Annual Meeting
Cohort 1 data from multiple dose ReSPECT- Leptomeningeal Metastases (LM) trial showed no dosage limiting toxicity ReSPECT-Glioblastoma (GBM) trial of...
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
One complete response and three partial responses observed in heavily pretreated ICI-secondary refractory patients in high dose cohorts Deep and durable...
Tilray Releases the Ultimate 2025 Holiday Drink Gift Guide, Celebrating Seasonal Sips and Moments of Connection from Coast to Coast
ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and...
Philips reiterates timing of 2026 outlook
December 4, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed...
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
LEXINGTON, Mass. and AMSTERDAM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing...
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
Not for distribution by US newswire or in United States TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD....
RadioMedix and Thor Medical enter supply agreement for thorium-228
OSLO, Norway and HOUSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Thor Medical ASA, a leading emerging supplier of alpha-emitters for...
Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI™ (berdazimer) Topical Gel, 10.3%
ZELSUVMI is the first and only FDA-approved at-home treatment for molluscum contagiosum, a highly contagious viral skin condition affecting an...
PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical")...
Agile Consulting Group Announces Key Partnership with LeadingAge Washington to Deliver Sales Tax Services to Member Organizations
ATLANTA, Dec. 4, 2025 /PRNewswire/ -- Agile Consulting Group, sales tax exemption and compliance experts, announced a new partnership with...
mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
MADRID, Dec. 4, 2025 /PRNewswire/ -- mAbxience, a Fresenius entity, and HP Inc., a global leader in technology, announce a new...
Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance
Powered by agentic AI, new features help regulatory teams improve accuracy and enable faster, more confident decisions across the product...
UMED Wins CES Innovation Awards® 2026, Redefining Bladder Care with World’s First Automated Irrigation System
Transforming bladder care from hospital-centered procedures to accessible, data-driven digital urologySEOUL, South Korea, Dec. 4, 2025 /PRNewswire/ -- UMED Inc,...
Wellgistics Health Announces that it will Distribute a Dream Bowl 2026 Meme Coin to Wellgistics Health Stockholders
TAMPA, FLORIDA / ACCESS Newswire / December 4, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader...
Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs
Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a...
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
Phase 2 clinical trial initiated to evaluate SEMA3A mAb as potential treatment for Alport syndromeMilestone payment to Evotec expected upon...
AI-Driven Personalized Nutrition and Wellness Solutions Market worth USD 17,867.16 MN by 2032 | Credence Research
LONDON, Dec. 4, 2025 /PRNewswire/ -- The global AI-Driven Personalized Nutrition and Wellness Solutions Market is entering an unprecedented phase...
Shinoda Dental Signs MOU with Global Milling Manufacturer, Expands CAD/CAM Portfolio with Leading Brands
With expanded access to brands like Planmeca, Roland, Dentsply Sirona, and Ivoclar, Shinoda Dental becomes a global CAD/CAM solutions hub....
BLACK PASTORS UNITED FOR EDUCATION (BPUE) WINS THE 2025 GREGOR G. PETERSON PRIZE IN VENTURE PHILANTHROPY
HARRISBURG, Pa., Dec. 3, 2025 /PRNewswire/ -- Black Pastors United for Education (BPUE), a faith-based nonprofit providing children with full-time...